Early-life exposure to toxic metals remains a major global public health concern, particularly for children, whose developing neuroendocrine and metabolic systems are highly vulnerable. Within the exposome and Developmental Origins of Health and Disease (DOHaD) frameworks, this narrative review synthesizes human evidence on pediatric exposure to lead (Pb), mercury (Hg), cadmium (Cd), and arsenic (As) and its associations with neurodevelopmental, metabolic, and endocrine outcomes. We primarily examined epidemiological studies, systematic reviews, and meta-analyses published between 2010 and 2025 that relied on biomonitoring-based exposure assessment and appropriate adjustment for socioeconomic status and passive smoking, while seminal earlier studies were considered to contextualize biological mechanisms and conceptual frameworks. The evidence for neurodevelopmental toxicity is the most consistent, with prenatal and early childhood exposure to Pb and Hg robustly associated with adverse cognitive, behavioral, and motor outcomes and no identified safe exposure threshold for lead. In contrast, associations with obesity and pubertal timing are more heterogeneous and metal-specific, reflecting nonlinear dose–response relationships, sex-specific susceptibility, and critical exposure windows. Emerging data indicate that metals may act as metabolism- and endocrine-disrupting chemicals, with effects amplified by mixture exposures and adverse social conditions, and partially modified by nutritional status. Overall, the findings support life-course–oriented, biomonitoring-based research and prevention strategies that address cumulative exposures and developmental vulnerability to reduce long-term disease risk.
Clinically isolated syndrome (CIS) represents the first demyelinating event suggestive of multiple sclerosis (MS), with variable risk of progression. This study aimed to identify clinical and paraclinical predictors of conversion to clinically definite MS in a cohort of 273 patients. Multivariate analysis demonstrated that periventricular and infratentorial MRI lesions, as well as oligoclonal bands, were the strongest independent predictors of conversion. Additional factors included abnormal somatosensory evoked potentials and polysymptomatic presentation. These findings highlight the importance of integrating radiological, immunological, and clinical markers to improve early risk stratification and guide therapeutic decision-making in patients with CIS.
Multiple sclerosis (MS) is associated with neuroinflammation, autonomic dysfunction, and dysregulation of the hypothalamic–pituitary–adrenal axis. This cross-sectional study evaluated the relationship between salivary cortisol, xerostomia, nitric oxide (NO), and anxiety in 39 patients with MS. Cortisol levels were higher in patients with xerostomia and showed a weak-to-moderate positive correlation with xerostomia (ρ = 0.32; p = 0.047) and a moderate negative correlation with NO (ρ = −0.46; p = 0.0035). No association was found with anxiety or disease duration. These findings suggest a potential neuroendocrine–salivary pathway linking stress biomarkers with glandular dysfunction in MS.
Postherpetic neuralgia (PHN) is a chronic neuropathic pain condition that arises following varicella-zoster virus reactivation and represents a significant clinical burden. Despite known risk factors, the genetic basis of PHN remains poorly understood. This study aimed to identify genetic variants associated with PHN through the secondary analysis of GWAS summary data (GCST012124). One genome-wide significant locus (KIF1B) and several suggestive variants (PTPRZ1, PRKCE, CXCR4) were identified. These genes converge on pathways related to axonal transport, neuroinflammation, and nociceptive sensitization. Findings support a multifactorial genetic contribution to PHN and highlight potential targets for future research and therapeutic development.